CAR-T therapy in China: eligibility and access

What an international patient should ask about approved uses, treatment centers, costs and follow-up.

What the treatment involves

CAR-T therapy modifies a patient’s T cells so they can recognize a target on cancer cells. Available products, approved indications and trial entry criteria are distinct. A hematology team reviews the specific diagnosis, prior treatment, current disease status and overall fitness before recommending a route.

What an eligibility review needs

Gather pathology and marker reports, treatment dates and responses, recent imaging or marrow studies, and any information about previous transplant or cell therapy. Ask the center which records must be reviewed before travel.

Plan for the entire course

Depending on the plan, care may include cell collection, manufacturing, preparatory treatment, infusion, monitoring and follow-up. Ask about risks such as cytokine release syndrome and neurologic side effects, which team manages complications, and what the quote covers if the stay extends.

Arrange follow-up before booking travel

Discuss how long you may need to remain near the center, what your local physician would need to take over follow-up, and how treatment complications or delays change the travel plan.

Continue reading

Browse this topic

Proton and heavy-ion therapy in China

The records, eligibility review and planning steps an international patient may encounter.

Read guide

Specialist pediatric cancer care in China

Points to cover when seeking a pediatric oncology review or discussing advanced treatment.

Read guide

Genetic testing and counseling in China

Questions about tumor sequencing, inherited conditions, sample handling and result interpretation.

Read guide

Sources and further reading

Free Pathway Scan

See whether a China pathway fits.

Start with a short overview of your condition, country, timing and insurance. Keep your full medical records for the next stage.